Molecular signatures of mood stabilisers highlight the role of the transcription factor REST/NRSF

Journal of Affective Disorders

Volumn 172, Issue , 2015, Pages 63-73

  Warburton, Alix ^a   Savage, Abigail L ^a   Myers, Paul ^a   Peeney, David ^a   Bubb, Vivien J ^a   Quinn, John P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Global Pattern Recognition; Mood disorders; Mood modifying drugs; Neuronal signalling; NRSF; Pathway analysis

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CIRCADIAN RHYTHM SIGNALING PROTEIN; DOPAMINE 3 RECEPTOR; ESTROGEN RECEPTOR; GLUTAMATE DECARBOXYLASE; LITHIUM; MOOD STABILIZER; NEU DIFFERENTIATION FACTOR; PROTEIN FOS; REELIN; RGS4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRSF; TRANSCRIPTION FACTOR REST; TRANSCRIPTOME; UNCLASSIFIED DRUG; VALPROIC ACID; LITHIUM DERIVATIVE; RE1-SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TRANQUILIZER;

ARTICLE; CELL TYPE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DESIGN; DRUG RESPONSE; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL LINE; PATTERN RECOGNITION; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TISSUE CULTURE; CELL LINE; GENETICS;

ANTIMANIC AGENTS; CELL LINE; HUMANS; LITHIUM COMPOUNDS; REPRESSOR PROTEINS; TRANSCRIPTOME; VALPROIC ACID;

EID: 84908431758     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.09.024     Document Type: Article

References (52)

1. The ENCODE Project Consortium, 2011. A user's guide to the encyclopedia of DNA elements (ENCODE) PLoS Biol. 9, e1001046.
2. Abramovitz, L., Shapira, T., Ben-Dror, I., Dror, V., Granot, L., Rousso, T., Landoy, E., Blau, L., Thiel, G., Vardimon, L., 2008. Dual role of NRSF/REST in activation and repression of the glucocorticoid response. J. Biol. Chem. 283, 110-119.
3. Akilesh, S., Shaffer, D.J., Roopenian, D., 2003. Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. Genome Res. 13, 1719-1727.
4. Asghari, V., Wang, J.F., Reiach, J.S., Young, L.T., 1998. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Mol. Brain Res. 58, 95-102.
5. Bronson, M.W., Hillenmeyer, S., Park, R.W., Brodsky, A.S., 2010. Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells. Mol. Endocrinol. 24, 1120-1135.
6. Chen, G., Huang, L.-D., Jiang, Y.-M., Manji, H.K., 2008. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem. 72, 1327-1330.
7. D'Souza, U.M., Powell-Smith, G., Haddley, K., Powell, T.R., Bubb, V.J., Price, T., McGuffin, P., Quinn, J.P., Farmer, A.E., 2013. Allele-specific expression of the serotonin transporter and its transcription factors following lamotrigine treatment in vitro. Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B, 474-483.
8. Di Daniel, E., Mudge, A.W., Maycox, P.R., 2005. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 7, 33-41.
9. Domschke, K., Tidow, N., Schrempf, M., Schwarte, K., Klauke, B., Reif, A., Kersting, A., Arolt, V., Zwanzger, P., Deckert, J., 2013. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation? Prog. Neuropsychopharmacol. Biol. Psychiatry 46, 189-196.
10. Fujimoto, N., Kitamura, S., 2004. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta. J. Steroid Biochem. Mol. Biol. 88, 53-59.
11. Furuta, M., Numakawa, T., Chiba, S., Ninomiya, M., Kajiyama, Y., Adachi, N., Akema, T., Kunugi, H., 2013. Estrogen, predominantly via estrogen receptor alpha, attenuates postpartum-induced anxiety- and depression-like behaviors in female rats. Endocrinology 154 (10), 3807-3816. http://dx.doi.org/10.1210/en.2012-2136, Epub 2013 Aug 2.
12. Gallagher, P., Malik, N., Newham, J., Young, A.H., Ferrier, I.N., Mackin, P., 2008. Antiglucocorticoid treatments for mood disorders. Cochrane Database of Syst. Rev., Issue 1. Art. no.: CD005168. http://dx.doi.org/10.1002/14651858.CD005168.pub2.
13. Gillies, S., Haddley, K., Vasiliou, S., Bubb, V.J., Quinn, J.P., 2009. The human neurokinin B gene, TAC3, and its promoter are regulated by Neuron Restrictive Silencing Factor (NRSF) transcription factor family. Neuropeptides 43, 333-340.
14. Hettema, J.M., An, S.S., Neale, M.C., Bukszar, J., van den Oord, E.J., Kendler, K.S., Chen, X., 2006. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol. Psychiatry 11, 752-762.
15. Hill, J., Breen, G., Quinn, J., Tibu, F., Sharp, H., Pickles, A., 2013. Evidence for interplay between genes and maternal stress in utero: monoamine oxidase A polymorphism moderates effects of life events during pregnancy on infant negative emotionality at 5 weeks. Genes Brain Behav. 12, 388-396.
16. Hing, B., Davidson, S., Lear, M., Breen, G., Quinn, J., McGuffin, P., MacKenzie, A., 2012. A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity. Biol. Psychiatry 71, 618-626.
17. Howard, M.R., Millward-Sadler, S.J., Vasilliou, A.S., Salter, D.M., Quinn, J.P., 2008. Mechanical stimulation induces preprotachykinin gene expression in osteoarthritic chondrocytes which is correlated with modulation of the transcription factor neuron restrictive silence factor. Neuropeptides 42, 681-686.
18. Jones, S., Kauer, J.A., 1999. Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. J. Neurosci. 19, 9780-9787.
19. Kantor, L., Park, Y.H., Wang, K.K., Gnegy, M., 2002. Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment. Eur. J. Pharmacol. 451, 27-35.
20. Karmakar, S., Jin, Y., Nagaich, A.K., 2013. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) alpha and activator protein 1 (AP1) in dexamethasone-mediated interference of ERalpha activity. J. Biol. Chem. 288, 24020-24034.
21. Karolewicz, B., Maciag, D., O'Dwyer, G., Stockmeier, C.A., Feyissa, A.M., Rajkowska, G., 2010. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int. J. Neuropsychopharmacol. 13, 411-420.
22. Le, T.P., Sun, M., Luo, X., Kraus, W.L., Greene, G.L., 2013. Mapping ERbeta genomic binding sites reveals unique genomic features and identifies EBF1 as an ERbeta interactor. PLoS One 8, e71355.
23. Lew, G.M., 1992. Microtubular tau protein after cocaine in cultured SH-SY5Y human neuroblastoma. Gen. Pharmacol. 23, 1111-1113.
24. Loe-Mie, Y., Lepagnol-Bestel, A.M., Maussion, G., Doron-Faigenboim, A., Imbeaud, S., Delacroix, H., Aggerbeck, L., Pupko, T., Gorwood, P., Simonneau, M., Moalic, J.M., 2010. SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Hum. Mol. Genet. 19, 2841-2857.
25. Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., Yang, T.H., Kim, H.M., Drake, D., Liu, X.S., Bennett, D.A., Colaiacovo, M.P., Yankner, B.A., 2014. REST and stress resistance in ageing and Alzheimer's disease. Nature 507, 448-454.
26. Lundorf, M.D., Buttenschon, H.N., Foldager, L., Blackwood, D.H., Muir, W.J., Murray, V., Pelosi, A.J., Kruse, T.A., Ewald, H., Mors, O., 2005. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B, 94-101.
27. Lupien, S.J., McEwen, B.S., Gunnar, M.R., Heim, C., 2009. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 10, 434-445.
28. Miyajima, F., Quinn, J.P., Horan, M., Pickles, A., Ollier, W.E., Pendleton, N., Payton, A., 2008. Additive effect of BDNF and REST polymorphisms is associated with improved general cognitive ability. Genes Brain Behav. 7, 714-719.
29. Nomura, M., Durbak, L., Chan, J., Smithies, O., Gustafsson, J.A., Korach, K.S., Pfaff, D.W., Ogawa, S., 2002. Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor beta knockout (betaERKO) male mice. Horm. Behav. 41, 288-296.
30. Otsuki, K., Uchida, S., Wakabayashi, Y., Matsubara, T., Hobara, T., Funato, H., Watanabe, Y., 2010. Aberrant REST-mediated transcriptional regulation in major depressive disorder. J. Psychiatr. Res. 44, 378-384.
31. Ozaki, N., Chuang, D.-M., 2002. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69, 2336-2344.
32. Pan, T., Li, X., Xie, W., Jankovic, J., Le, W., 2005. Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett. 579, 6716-6720.
33. Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A., Klein, P.S., 2001. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734-36741.
34. Powell, T.R., Schalkwyk, L.C., Heffernan, A.L., Breen, G., Lawrence, T., Price, T., Farmer, A.E., Aitchison, K.J., Craig, I.W., Danese, A., Lewis, C., McGuffin, P., Uher, R., Tansey, K.E., D'Souza, U.M., 2013. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identi.ed as putative transcriptomic biomarkers for escitalopram response. Eur. Neuropsychopharmacol. 23, 1105-1114.
35. Quinn, J.P., 1991. Variation in the composition of the AP1 complex in PC12 cells following induction by NGF and TPA. Mol. Cell. Neurosci. 2, 253-258.
36. Quinn, J.P., Farina, A.R., Gardner, K., Krutzsch, H., Levens, D., 1989a. Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. Mol. Cell. Biol. 9, 4713-4721.
37. Quinn, J.P., Takimoto, M., Iadarola, M., Holbrook, N., Levens, D., 1989b. Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers. J. Virol. 63, 1737-1742.
38. Quinn, J.P., Warburton, A., Myers, P., Savage, A.L., Bubb, V.J., 2013. Polymorphic variation as a driver of differential neuropeptide gene expression. Neuropeptides 47, 395-400.
39. Roberts, J., Scott, A.C., Howard, M.R., Breen, G., Bubb, V.J., Klenova, E., Quinn, J.P., 2007. Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat. J. Neurosci. 27, 2793-2801.
40. Rosenbloom, K.R., Sloan, C.A., Malladi, V.S., Dreszer, T.R., Learned, K., Kirkup, V.M., Wong, M.C., Maddren, M., Fang, R., Heitner, S.G., Lee, B.T., Barber, G.P., Harte, R.A., Diekhans, M., Long, J.C., Wilder, S.P., Zweig, A.S., Karolchik, D., Kuhn, R.M., Haussler, D., Kent, W.J., 2013. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 41, D56-D63.
41. Shyu, K.G., Wang, B.W., Yang, Y.H., Tsai, S.C., Lin, S., Lee, C.C., 2004. Amphetamine activates connexin43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway. Cardiovasc. Res. 63, 98-108.
42. Spencer, E.M., Chandler, K.E., Haddley, K., Howard, M.R., Hughes, D., Belyaev, N.D., Coulson, J.M., Stewart, J.P., Buckley, N.J., Kipar, A., Walker, M.C., Quinn, J.P., 2006. Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiol. Dis. 24, 41-52.
43. Spijker, A.T., van Rossum, E.F., 2012. Glucocorticoid sensitivity in mood disorders. Neuroendocrinology 95, 179-186.
44. Sugden, K., Pariante, C.M., McGuffin, P., Aitchison, K.J., D'Souza, U.M., 2010. Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line. J. Psychopharmacol. 24, 1253-1259.
45. Takimoto, M., Quinn, J.P., Farina, A.R., Staudt, L.M., Levens, D., 1989. fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. J. Biol. Chem. 264, 8992-8999.
46. Thompson, M., Weickert, C.S., Wyatt, E., Webster, M.J., 2009. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J. Psychiatr. Res. 43, 970-977.
47. Ukai, W., Ishii, T., Hashimoto, E., Tateno, M., Yoshinaga, T., Ono, T., Watanabe, K., Watanabe, I., Shirasaka, T., Saito, T., 2009. The common aspects of pathophysiolgy of alcoholism and depression. Nihon Arukoru Yakubutsu Igakkai Zasshi 44, 704-711.
48. Warburton, A., Breen, G., Rujescu, D., Bubb, V.J., Quinn, J.P., 2014. Characterization of a REST-regulated internal promoter in the schizophrenia genome-wide associated gene MIR137. Schizophr. Bull..
49. Weber, H., Scholz, C.J., Domschke, K., Baumann, C., Klauke, B., Jacob, C.P., Maier, W., Fritze, J., Bandelow, B., Zwanzger, P.M., Lang, T., Fehm, L., Strohle, A., Hamm, A., Gerlach, A.L., Alpers, G.W., Kircher, T., Wittchen, H.U., Arolt, V., Pauli, P., Deckert, J., Reif, A., 2012. Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder. PLoS One 7, e37651.
50. Wolkowitz, O.M., Reus, V.I., 1999. Treatment of depression with antiglucocorticoid drugs. Psychosom. Med. 61, 698-711.
51. Wolkowitz, O.M., Reus, V.I., Chan, T., Manfredi, F., Raum, W., Johnson, R., Canick, J., 1999. Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol. Psychiatry 45, 1070-1074.
52. Zhang, M.M., Xiao, C., Yu, K., Ruan, D.Y., 2003. Effects of sodium valproate on synaptic plasticity in the CA1 region of rat hippocampus. Food Chem. Toxicol. 41, 1617-1623.